Aurobindo Pharma receives USFDA approval for Bivalirudin injection
The estimated market size of Bivalirudin injection is US$ 101 million for the twelve months ending May 2018 according to IQVIA
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Lupin’s Mandideep facility gets approval from EDQM
The unit was inspected by EDQM during March 2018
Twin USFDA approvals for Morepen Labs’ Bulk Drugs (API) facilities
Baddi facility gets US FDA nod for bulk drug 'Atorvastatin' and Masulkhana facility for 'Montelukast'
Wockhardt sets up its first manufacturing and R&D unit in Middle East
Wockhardt inaugurates a ‘state-of-the-art’ manufacturing facility for the production and packaging of sterile dry powder injection…
Zydus Cadila gets US FDA nod to market Vardenafil tablets
The product will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad
Gujarat FDCA, bioMerieux India conducts workshop on pharmaceutical microbiology
65 drugs inspector of FDCA participated in this knowledge sharing workshop
International Women Health and Breast Cancer Conference, coming soon
The event will focus on how the health of women will overall improve the health of the world
Jubilant Life Sciences pharma revenue is at INR 1,181 crore,up by 46%
The international revenues are at INR 1,507 crore, around 72 per cent of sales
Dr Reddy’s saw a year-on-year growth of 16% in the PSAI sector
Revenues from India were at INR 6.1 billion and year-on-year growth was 30 per cent